Amalgamated Bank Coherus Bio Sciences, Inc. Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

A detailed history of Amalgamated Bank transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 3,609 shares of CHRS stock, worth $5,341. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,609

Previous 3,609 -0.0%

Holding current value

$5,341

Previous $6,000 33.33%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$1.58 - $2.51 $1,625 - $2,582	1,029 Added 39.88%	3,609 $6,000
Q1 2024 Apr 23, 2024	SELL	$2.02 - $3.14 $21,904 - $34,050	-10,844 Reduced 80.78%	2,580 $6,000
Q4 2023 Feb 06, 2024	BUY	$1.59 - $3.85 $4,033 - $9,767	2,537 Added 23.3%	13,424 $45,000
Q3 2023 Nov 08, 2023	SELL	$3.74 - $5.45 $75,963 - $110,694	-20,311 Reduced 65.1%	10,887 $41,000
Q2 2023 Aug 11, 2023	BUY	$3.79 - $8.3 $2,198 - $4,814	580 Added 1.89%	31,198 $133,000
Q1 2023 May 02, 2023	SELL	$5.89 - $10.52 $12,846 - $22,944	-2,181 Reduced 6.65%	30,618 $209,000
Q3 2022 Nov 09, 2022	BUY	$7.17 - $13.87 $2,767 - $5,353	386 Added 1.19%	32,799 $315,000
Q2 2022 Aug 15, 2022	BUY	$5.86 - $13.23 $6,598 - $14,896	1,126 Added 3.6%	32,413 $235,000
Q1 2022 Jun 30, 2022	SELL	$10.92 - $16.41 $21,086 - $31,687	-1,931 Reduced 5.81%	31,287 $404,000
Q4 2021 Feb 15, 2022	SELL	$15.81 - $18.99 $13,849 - $16,635	-876 Reduced 2.57%	33,218 $530,000
Q3 2021 Oct 29, 2021	SELL	$12.68 - $17.79 $8,444 - $11,848	-666 Reduced 1.92%	34,094 $548,000
Q2 2021 Aug 16, 2021	BUY	$12.95 - $15.41 $450,142 - $535,651	34,760 New	34,760 $481,000
Q2 2020 Aug 10, 2020	SELL	$14.43 - $19.16 $149,783 - $198,880	-10,380 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$11.67 - $22.53 $5,041 - $9,732	-432 Reduced 4.0%	10,380 $168,000
Q4 2019 Feb 13, 2020	BUY	$16.33 - $21.37 $176,559 - $231,052	10,812 New	10,812 $195,000
Q3 2019 Nov 13, 2019	SELL	$16.3 - $23.37 $162,185 - $232,531	-9,950 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$13.1 - $22.1 $130,345 - $219,895	9,950 New	9,950 $220,000

Others Institutions Holding CHRS

# of Institutions

135

Shares Held

77.9M

Call Options Held

40.7K

Put Options Held

50.1K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $115M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Coherus Bio Sciences, Inc. Transaction History